| Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells M Perdicchio, JM Ilarregui, MI Verstege, LAM Cornelissen, STT Schetters, ... Proceedings of the National Academy of Sciences 113 (12), 3329-3334, 2016 | 156 | 2016 |
| Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells M Perdicchio, LAM Cornelissen, I Streng-Ouwehand, S Engels, ... Oncotarget 7 (8), 8771-8782, 2016 | 99 | 2016 |
| Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin SA Dusoswa, J Verhoeff, E Abels, SP Méndez-Huergo, DO Croci, ... Proceedings of the National Academy of Sciences 117 (7), 3693-3703, 2020 | 64 | 2020 |
| A bitter sweet symphony: immune responses to altered O-glycan epitopes in cancer LAM Cornelissen, SJ Van Vliet Biomolecules 6 (2), 26, 2016 | 53 | 2016 |
| Siglec signaling in the tumor microenvironment EJH van Houtum, C Büll, LAM Cornelissen, GJ Adema Frontiers in Immunology 12, 790317, 2021 | 50 | 2021 |
| Tn antigen expression contributes to an immune suppressive microenvironment and drives tumor growth in colorectal cancer LAM Cornelissen, A Blanas, A Zaal, JC van der Horst, LJW Kruijssen, ... Frontiers in oncology 10, 1622, 2020 | 48 | 2020 |
| Glycan modification of antigen alters its intracellular routing in dendritic cells, promoting priming of T cells I Streng-Ouwehand, NI Ho, M Litjens, H Kalay, MA Boks, ... Elife 5, e11765, 2016 | 39 | 2016 |
| Transcriptional activation of fucosyltransferase (FUT) genes using the CRISPR-dCas9-VPR technology reveals potent N-glycome alterations in colorectal cancer cells A Blanas, LAM Cornelissen, M Kotsias, JC van der Horst, HJ van de Vrugt, ... Glycobiology 29 (2), 137-150, 2019 | 35 | 2019 |
| Disruption of sialic acid metabolism drives tumor growth by augmenting CD8+ T cell apoptosis LAM Cornelissen, A Blanas, JC van der Horst, L Kruijssen, A Zaal, ... International journal of cancer 144 (9), 2290-2302, 2019 | 33 | 2019 |
| Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ RJE Van den Bijgaart, F Schuurmans, JJ Fütterer, M Verheij, ... Frontiers in Immunology 12, 617365, 2021 | 27 | 2021 |
| Sialic acid blockade in dendritic cells enhances CD8+ T cell responses by facilitating high-avidity interactions N Balneger, LAM Cornelissen, M Wassink, SJ Moons, TJ Boltje, ... Cellular and Molecular Life Sciences 79 (2), 98, 2022 | 20 | 2022 |
| Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma K Rabold, M Zoodsma, I Grondman, Y Kuijpers, M Bremmers, M Jaeger, ... Nature Communications 13 (1), 6149, 2022 | 5 | 2022 |
| Tumor-associated glycan structures: friend or foe in immunity to cancer? LAM Cornelissen | | 2019 |
